EMILY LA VALLEY: Open Payments
NPI 1336702174 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 12 payments from 9 companies in 2025. Trend: 2023 $683 · 2024 $867 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| ABBVIE INC. | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Dexcom, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| PFIZER INC. | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
Products named: VYEPTI, FARXIGA, Auvelity, VAXNEUVANCE, Dexcom G6 Transmitter, Veozah, NURTEC ODT, Wegovy.
Industry payments across MI — which companies pay providers there.
